Oxidative stress and endothelial dysfunction: Clinical evidence and therapeutic implications

Trends in Cardiovascular Medicine

Volumn 24, Issue 4, 2014, Pages 165-169

  Higashi, Yukihito ^a,b   Maruhashi, Tatsuya ^c   Noma, Kensuke ^a,b   Kihara, Yasuki ^c  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; URIC ACID; XANTHINE OXIDASE;

ANIMAL; GILBERT DISEASE; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RENOVASCULAR HYPERTENSION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; BILIRUBIN; ENDOTHELIUM, VASCULAR; GILBERT DISEASE; HUMANS; HYPERTENSION, RENOVASCULAR; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; URIC ACID; XANTHINE OXIDASE;

EID: 84899489650     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2013.12.001     Document Type: Review

References (39)

1. Abraham N.G., Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacological Reviews 2008, 60:79-127.
2. Bosma P.J., Chowdhury J.R., Bakker C., et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. New England Journal of Medicine 1995, 333:1171-1175.
3. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research 2000, 87:840-844.
4. Dzau V.J. Theodore Cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001, 37:1047-1052.
5. George J., Carr E., Davies J., et al. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006, 114:2508-2516.
6. Gilbert A., Lereboullet P. La cholémie simple familiale. Semaine Medicale 1901, 21:241-243.
7. Guzik T.J., West N.E., Black E., et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circulation Research 2000, 86:E85-E90.
8. Hayden M.R., Tyagi S.C. Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress. Cardiovascular Diabetology 2003, 2:1-10.
9. Heitzer T., Schlinzig T., Krohn K., et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001, 104:2673-2678.
10. Higashi Y., Sasaki S., Nakagawa K., et al. Endothelial function and oxidative stress in renovascular hypertension. New England Journal of Medicine 2002, 346:1954-1962.
11. Higashi Y., Sasaki S., Nakagawa K., et al. Tetrahydrobiopterin improves impaired endothelium-dependent vasodilation in patients with essential hypertension. American Journal of Hypertension 2002, 15:326-332.
12. Higashi Y., Sasaki S., Nakagawa K., et al. Tetrahydrobiopterin improves aging-related impairment of endothelium-dependent vasodilation through increase in nitric oxide production and decrease in reactive oxygen species. Atherosclerosis 2006, 186:390-395. [Supplements].
13. Inoguchi T., Sasaki S., Kobayashi K., et al. Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. Journal of American Medical Association 2007, 298:1398-1400.
14. Kapitulnik J. Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Molecular Pharmacology 2004, 66:773-779.
15. Kaufman S. New tetrahydrobiopterin-dependent systems. Annual Review of Nutrition 1993, 13:261-286.
16. Kuzkaya N., Weissmann N., Harrison D.G., et al. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. Journal of Biological Chemistry 2003, 278:22546-22554.
17. Lerman A., Zeiher A.M. Endothelial function: cardiac events. Circulation 2005, 111:363-368.
18. *28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006, 114:1476-1481.
19. Maruhashi T., Soga J., Idei N., et al. Hyperbilirubinemia, augmentation of endothelial function and decrease in oxidative stress in Gilbert syndrome. Circulation 2012, 126:598-603.
20. Moat S.J., McDowell I.F. Homocysteine and endothelial function in human studies. Seminars in Vascular Medicine 2005, 5:172-182.
21. Münzel T., Gori T., Bruno R.M., et al. Is oxidative stress a therapeutic target in cardiovascular disease?. European Heart Journal 2010, 31:2741-2748.
22. Muto A., Tashiro S., Nakajima O., et al. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 2004, 429:566-571.
23. Owens D., Evans J. Population studies on Gilbert's syndrome. Journal of Medical Genetics 1975, 12:152-156.
24. Rodriguez-Crespo I., Gerber N.C., Ortiz de Montellano P.R. Endothelial nitric-oxide synthase. Journal of Biological Chemistry 1996, 271:11462-11467.
25. Ross R. Atherosclerosis-an inflammatory disease. New England Journal of Medicine 1999, 340:115-126.
26. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101:1899-1906.
27. Setoguchi S., Hirooka Y., Eshima K., et al. Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure. Journal of Cardiovascular Pharmacology 2003, 39:363-368.
28. Sieg A., Arab L., Schlierf G., et al. Prevalence of Gilbert's syndrome in Germany. Deutsche Medizinische Wochenschrift 1987, 112:1206-1208.
29. Sowers J.R. Hypertension, angiotensin II, and oxidative stress. New England Journal of Medicine 2002, 346:1999-2001.
30. Stocker R., Yamamoto Y., McDonagh A.F., et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235:1043-1046.
31. Stoes E., Kastelein J., Cosentino F., et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. Journal of Clinical Investigation 1997, 99:41-46.
32. Sun J., Hoshino H., Takaku K., et al. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO Journal 2002, 21:5216-5224.
33. Touyz R.M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 2004, 44:248-252.
34. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989, 2:997-1000.
35. Vanhoutte P.M. Endothelium and control of vascular function: state of the art lecture. Hypertension 1989, 13:658-667.
36. Virdis A., Bacca A., Colucci R., et al. Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation. Hypertension 2013, 62:337-344.
37. Vítek L., Jirsa M., Brodanová M., et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002, 160:449-456.
38. Yiginer O., Ozcelik F., Inanc T., et al. Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome. Clinical Research in Cardiology 2008, 97:334-340.
39. Yu M.A., Sanchez-Lozada L.G., Johnson R.J., et al. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. Journal of Hypertension 2010, 28:1234-1242.